Search
As a new generation of hemostatic agents, Carbazochrome sodium sulfonate can reduce the permeability of capillaries, improve the retraction of capillary rupture ends, and can be used for a variety of bleeding caused by increased capillary permeability.
Carbazochrome sodium sulfonate does not contain salicylic acid groups, so it does not produce hemolysis, does not affect hematopoietic function, and at the same time has little stimulation, safe medication, it has no adrenal effect, will not cause blood pressure, heart rate fluctuations; Does not affect the coagulation mechanism, has a rapid onset of action and a long-lasting effect. Carbazochrome sodium sulfonate is mainly used for a variety of bleeding caused by increased capillary permeability, such as bleeding from urinary system, upper gastrointestinal tract, respiratory tract, and obstetrics and gynecology. Carbazochrome sodium sulfonate has a significant effect on urinary bleeding, and can also be used for the prevention and treatment of trauma and surgical bleeding.
Items | Standard | Results |
Appearance | Yellow crystalline powder | Complies |
pH value | 5.0~6.0 | 5.60 |
Water | 13.0~16.0% | 14.7% |
Heavy metals | ≤20PPM | Complies |
Related substances | Carbazochrom | Complies |
Assay | ≥98.5% | 99.2% |
Product parameters | |
Cas number: | 51460-26-5 |
Appearance: | Yellow crystalline powder |
Purity: | 98.5%min |
Package details: | 1kg/foil bag; 25kg/drum |
Brand: | Fortunachem |
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail: